Akso Health Group (FRA:8HX)
Germany · Delayed Price · Currency is EUR 0.7700
+0.0350 (4.76%)
At close: Aug 26, 2026
Akso Health Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 723 | 1,694 | 393 | 157 | 7 | 35 | |
Market Cap Growth | -13.58% | 330.64% | 150.09% | 2005.36% | -78.52% | 35.68% |
Enterprise Value | 724 | 1,686 | 315 | 158 | 7 | 32 |
Last Close Price | 0.73 | 1.98 | 1.05 | 1.05 | 0.25 | 1.53 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PS Ratio | 60.23 | 141.22 | 28.77 | 70.29 | 0.62 | 6.44 |
PB Ratio | 4.60 | 10.80 | 2.13 | 1.23 | 0.92 | 3.15 |
P/TBV Ratio | 4.61 | 10.80 | 2.36 | 1.23 | 0.93 | 3.15 |
P/FCF Ratio | - | - | 415.76 | 125.59 | - | - |
P/OCF Ratio | - | - | 361.20 | 125.59 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 61.12 | 140.56 | 23.05 | 70.65 | 0.59 | 5.86 |
EV/FCF Ratio | - | - | 333.10 | 126.24 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 1.10 | 3.03 |
Debt / FCF Ratio | - | - | 2.04 | 1.48 | - | - |
Net Debt / Equity Ratio | 0.01 | 0.01 | -0.87 | -0.60 | 0.20 | 1.53 |
Net Debt / EBITDA Ratio | -1.35 | -1.35 | 98.21 | - | -0.12 | -7.70 |
Net Debt / FCF Ratio | -0.17 | -0.17 | -170.28 | -61.55 | -0.54 | -2.17 |
Asset Turnover | 0.07 | 0.07 | 0.08 | 0.03 | 0.32 | 0.13 |
Inventory Turnover | 70.92 | 70.92 | 78.96 | 2.44 | 2.51 | - |
Quick Ratio | 0.17 | 0.17 | 12.83 | 23.70 | 1.34 | 0.37 |
Current Ratio | 21.77 | 21.77 | 14.20 | 39.52 | 1.76 | 1.24 |
Return on Equity (ROE) | -9.85% | -9.85% | -80.26% | -12.38% | -123.87% | -27.75% |
Return on Assets (ROA) | -1.24% | -1.24% | -1.37% | -6.64% | -21.42% | -3.25% |
Return on Invested Capital (ROIC) | -2.18% | -3.84% | -9.78% | -26.24% | -68.50% | -10.64% |
Return on Capital Employed (ROCE) | -2.20% | -2.20% | -2.00% | -6.20% | -161.40% | -20.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -2.24% | -0.96% | -31.75% | -5.57% | -16.75% | -43.61% |
FCF Yield | -1.54% | -0.66% | 0.24% | 0.80% | -40.08% | -22.33% |
Buyback Yield / Dilution | -153.50% | -153.50% | -504.37% | -106.30% | -15.07% | -22.06% |
Total Shareholder Return | -153.50% | -153.50% | -504.37% | -106.30% | -15.07% | -22.06% |